Concepedia

Publication | Open Access

Safety and efficacy of nusinersen in spinal muscular atrophy: The <scp>EMBRACE</scp> study

107

Citations

21

References

2021

Year

Abstract

Nusinersen demonstrated a favorable long-term benefit-risk profile in this broad population of individuals with infantile- or later-onset SMA.

References

YearCitations

Page 1